A detailed history of Single Point Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Single Point Partners, LLC holds 905 shares of DHR stock, worth $217,200. This represents 0.05% of its overall portfolio holdings.

Number of Shares
905
Previous 967 6.41%
Holding current value
$217,200
Previous $224,000 0.89%
% of portfolio
0.05%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$224.58 - $256.19 $13,923 - $15,883
-62 Reduced 6.41%
905 $226,000
Q4 2023

Jan 11, 2024

BUY
$185.1 - $233.13 $23,692 - $29,840
128 Added 15.26%
967 $224,000
Q3 2023

Oct 12, 2023

BUY
$233.08 - $265.59 $195,554 - $222,830
839 New
839 $208,000
Q1 2023

Apr 06, 2023

BUY
$239.75 - $277.0 $26,612 - $30,747
111 Added 7.75%
1,543 $389,000
Q4 2022

Jan 10, 2023

SELL
$241.42 - $282.29 $22,693 - $26,535
-94 Reduced 6.16%
1,432 $380,000
Q3 2022

Oct 07, 2022

BUY
$247.06 - $1507.4 $494 - $3,014
2 Added 0.13%
1,526 $394,000
Q2 2022

Jul 29, 2022

BUY
$237.11 - $299.66 $61,648 - $77,911
260 Added 20.57%
1,524 $386,000
Q1 2022

Apr 28, 2022

BUY
$257.27 - $315.76 $63,802 - $78,308
248 Added 24.41%
1,264 $371,000
Q4 2021

Jan 27, 2022

BUY
$292.08 - $329.01 $296,753 - $334,274
1,016 New
1,016 $334,000
Q3 2021

Oct 25, 2021

SELL
$272.21 - $332.43 $285,276 - $348,386
-1,048 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$225.08 - $271.69 $3,601 - $4,347
16 Added 1.55%
1,048 $281,000
Q1 2021

Apr 30, 2021

BUY
$212.38 - $245.9 $219,176 - $253,768
1,032 New
1,032 $232,000
Q4 2020

Jan 12, 2021

SELL
$212.5 - $245.46 $220,787 - $255,032
-1,039 Closed
0 $0
Q3 2020

Oct 30, 2020

BUY
$177.16 - $215.33 $184,069 - $223,727
1,039 New
1,039 $224,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Single Point Partners, LLC Portfolio

Follow Single Point Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Single Point Partners, LLC with notifications on news.